Compare Moderna, Inc. (MRNA) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance

Moderna, Inc.Trade

Virgin Galactic Holdings, Inc.Trade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Virgin Galactic Holdings, Inc. — how do they compare? Moderna, Inc. trades at $60.83 (market cap $23.88B), while Virgin Galactic Holdings, Inc. trades at $3.29 (market cap $488.94M). The key difference: Moderna, Inc. is far larger — about 48.8× Virgin Galactic Holdings, Inc.'s market cap, and Moderna, Inc. is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals.

	MRNA	SPCE
Market Cap	$23.88B	$488.94M
Sector	Health	Industrials
52-Week High	$81.80	$7.52
52-Week Low	$22.36	$2.17
Enterprise Value	$20.03B	$588.79M

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

New report analyzes 1,350+ precision medicine deals from 2019-2026, revealing market trends and deal structures.Researchandmarkets.Com · 4 days agoNeutral Global influenza vaccine market to grow to $13.32B by 2030, driven by aging population and vaccine innovationsResearchandmarkets.Com · 4 days agoNeutral View details →

SPCE

SpaceX shares fall 5% after post-IPO rally fades amid heavy AI spending concerns24/7 Wall Street · 19 hours agoBearish View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Virgin Galactic Holdings, Inc.

Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.